NAPA Reauthorization Act
This bill extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias.
In particular, the bill incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline.
The bill also expands the Advisory Council on Alzheimer's Research, Care, and Services to include additional members, such as (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice and the Office of Management and Budget).
[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 619 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 619
To extend the National Alzheimer's Project.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 30, 2023
Mr. Tonko (for himself, Mr. Smith of New Jersey, and Ms. Waters)
introduced the following bill; which was referred to the Committee on
Energy and Commerce
_______________________________________________________________________
A BILL
To extend the National Alzheimer's Project.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``NAPA Reauthorization Act''.
SEC. 2. EXTENSION OF PROJECT.
Section 2 of the National Alzheimer's Project Act (42 U.S.C. 11225)
is amended--
(1) in subsection (c)--
(A) in paragraph (2), by striking ``and
coordination of'' and inserting ``on, and coordination
of,'';
(B) in paragraph (4)--
(i) by redesignating subparagraphs (A) and
(B) as subparagraphs (B) and (C), respectively;
and
(ii) by inserting before subparagraph (B),
as so redesignated, the following:
``(A) promotion of healthy aging and reduction of
risk factors for Alzheimer's;'';
(C) in paragraph (5), by striking ``; and'' and
inserting a semicolon;
(D) by redesignating paragraph (6) as paragraph
(7); and
(E) by inserting after paragraph (5) the following:
``(6) provide information on, and promote the adoption of,
healthy behaviors that may reduce the risk of cognitive decline
and promote and protect cognitive health; and'';
(2) in subsection (d)(2)--
(A) by inserting ``, across public and private
sectors,'' after ``Nation's progress''; and
(B) by inserting ``, including consideration of
public-private collaborations, as appropriate'' before
the period;
(3) in subsection (e)--
(A) in paragraph (2)--
(i) in subparagraph (A), by adding at the
end the following:
``(xi) A designee of the Department of
Justice.
``(xii) A designee of the Federal Emergency
Management Agency.
``(xiii) A designee of the Social Security
Administration.
``(xiv) A designee of the Office of
Management and Budget.
``(xv) 1 or more other designees of the
Department of Health and Human Services, as
determined by the Secretary of Health and Human
Services.''; and
(ii) in subparagraph (B)--
(I) in the matter preceding clause
(i), by striking ``12'' and inserting
``14'';
(II) in clause (v)--
(aa) by striking ``2
researchers'' and inserting ``3
researchers''; and
(bb) by striking ``; and''
and inserting ``, including at
least one researcher with
demonstrated experience in
recruitment and retention of
diverse cohorts of clinical
trial participants;'';
(III) in clause (vi), by striking
the period and inserting ``; and''; and
(IV) by adding at the end the
following:
``(vii) an individual with a diagnosis of
Alzheimer's disease.'';
(B) in paragraph (5)--
(i) in subparagraph (A)--
(I) by striking ``an initial
evaluation'' and inserting ``annual
evaluations''; and
(II) by striking ``research,
clinical'' and inserting ``research,
risk reduction, public health,
clinical'';
(ii) in subparagraph (B), by striking
``initial'';
(iii) in subparagraph (C)--
(I) in the matter preceding clause
(i), by striking ``initial''; and
(II) in clause (ii), by inserting
``and reduce disparities'' before the
semicolon; and
(iv) in subparagraph (D), by striking
``annually thereafter, an evaluation'' and
inserting ``annual evaluations''; and
(C) in paragraph (6), by striking ``2025'' and
inserting ``2035'';
(4) in subsection (g)(3)(A)(ii), by inserting ``and reduce
disparities'' before the semicolon; and
(5) in subsection (h), by striking ``2025'' and inserting
``2035''.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Subcommittee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 26 - 0.
Committee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 43 - 0.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-526.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-526.
Placed on the Union Calendar, Calendar No. 438.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line